-880.34
79,454.47
-1.1%
Market Closed
1,377.75
-1.93%
1,889.2
-1.93%
-5.25
3,442.2
-0.15%
1,848.25
-1.21%
1,388.7
-3.16%
10.65
779.4
1.39%
1,507.45
-0.25%
2,333.95
-0.9%
8,640.2
-2.02%
-6.85
423.5
-1.5%
786.8
0.72%
3,445.7
3.77%
1,569.9
-0.63%
1,744.85
-1.23%
2,103.75
-0.11%
12,252.35
-1%
2,982.75
-1.59%
-17.85
1,153.35
-1.44%
11,373.6
-2.15%
-5.15
334.6
-1.52%
1,970.3
-1.77%
147.35
3,510.8
4.38%
4,500.9
1.84%
1.65
234.75
0.49%
1,307.1
-1.73%
299.55
-2.7%
708.5
3.9%
2,251.75
-1.48%
3,973.3
0.02%
0.65
241.9
0.27%
382.65
-0.66%
956.85
0.19%
315.75
2.92%
-17.3
2,323.8
-0.74%
2,300.35
0.02%
226.95
-1.09%
7,683.5
-0.58%
513.5
-1.26%
139.95
-0.46%
5,100.05
-0.52%
-114.1
5,114.15
-2.18%
2,633.6
-2.42%
142.75
-0.63%
408.1
0.16%
1,699.1
-1.76%
496.3
1.52%
407.85
0.2%
6,001.1
1.08%
248.1
-1.25%
-23.75
631.5
-2.79%
-880.34
79454.47
-1.1%
Market Closed

CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Union Budget 2025: Strengthening Healthcare and Pharma Sectors!

The Union Budget 2025 unveils transformative measures for the Healthcare and Pharma sectors, focusing on infrastructure, education, and affordability.

DSIJ Intelligence 0 176 Article rating: 5.0

The Union Budget 2025 unveils transformative measures for the Healthcare and Pharma sectors, focusing on infrastructure, education, and affordability. 

Special Feature On Pharmaceutical & Healthcare Industry

Keeping Good Health

Ninad Ramdasi 1 569 Article rating: 3.0

The corona virus pandemic drew everyone's attention to the need for basic medical facilities across the country, elevating the pharmaceutical and healthcare industries and compelling the government to pay greater attention to them. Mandar Wagh describes how being a major participant in terms of both volume and value globally, the government's emphasis and initiatives all contribute to the success of the industry

Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it?

Advent is expected to buy 51 per cent of the promoter’s stake in the company and launch an open offer for an additional 26 per cent

DSIJ Intelligence 0 1320 Article rating: 4.3

The company released a press release on Monday, stating Advent International has entered into definitive agreement to acquire significant stake in the company and intends to explore the merger of  its portfolio company

This pharma company received USDA approval for a generic drug which clocked over Rs 90 crore in sales, do you own it?

The company is ranked among the world’s top 100 biopharmaceutical companies and among the world’s top 50 companies in the off-patent sector.

DSIJ Intelligence 0 1085 Article rating: 4.4

Glenmark Pharmaceuticals Ltd is an innovation-driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses

This pharma company stock went 8 per cent high, do you own it?

With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

DSIJ Intelligence-1 0 1433 Article rating: 5.0

This pharma company stock went 8 per cent high, do you own it?                                                                                                                                                                                                       With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

Upcoming collaboration: Two leading pharma company stocks to watch out for

US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns

DSIJ Intelligence-1 0 2065 Article rating: 4.5

Upcoming collaboration: Two leading pharma company stocks to watch out for                                                                                                                                                                                            US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns.

Shilpa Medicare skyrockets by 10.47 per cent on a weak market day!

The board of the company also has recommended a dividend of Rs 1.10 per equity share for the financial year ended March 31, 2022.  

DSIJ Intelligence 0 563 Article rating: 5.0

The shares of Shilpa Medicare soared 10.47 per cent to Rs 453.25 on BSE after the company announced promising results for the quarter that ended on March 31, 2022.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR